Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Bullboard (TSX:GUD)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Comment by gudisgoodon Feb 24, 2023 5:27am

RE:I Like this Company - BUT

It's difficult to estimate how much covid slowed GUD down... but certainly it had some effect. On the other hand, we were able to sell infectious diseases product for covid treatments. These ...more  
122
Discussion
Post by GoldenInvestoron Feb 23, 2023 11:03pm

Thanks CC

You're right!  This company has been stuck in the same valuation range for a long time! I think irrelevant is the best descriptor here. the stock price doesn't mean much, until it ...more  
341
Comment by Chianchinon Feb 23, 2023 9:46pm

RE:Average estimate of top 5 analysts

That average estimate has been in the same range for te past 8 years. How many times does a prediction needs to fail before being declared false, irrelevant and or insane?  8  time is good ...more  
54
Discussion
Post by GoldenInvestoron Feb 23, 2023 8:18pm

Average estimate of top 5 analysts

$7.51 based on price targets of 5 top GUD analysts.  ranging from $5.40 - $10.15  
189
Discussion
Post by schocoron Feb 23, 2023 4:59pm

I Like this Company - BUT

I have followed this comapny for about 2 years now; I like the strategy and I like the Chairman's (goodman?) experience with this business model. Proven success.  BUT In the last 2 years ...more  
338
Discussion
Comment by EbbFlow88on Feb 23, 2023 8:49am

RE:Expectations for next Q results are low

I think those two things have been true for a while now lol.. low expectations and impatience.  There will likely be some mark to market losses in the funds ending 2022, which will probably ...more  
90
Discussion
Comment by Chianchinon Feb 21, 2023 2:51pm

RE:Expectations for next Q results are low

I will start buying at $2.50
57
Discussion
Post by Snowballgrowthon Feb 19, 2023 5:41pm

Expectations for next Q results are low

Expectations are very low and investors are now impatient. Let see, next results should available in a month or so. At least Tafasitamab had been submitted for regulatory review in Brazil.. 
339
Discussion
Comment by Eoj123on Feb 12, 2023 12:40pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Cheap Valuation

Many years later and this pos is still low five bucks......
101
Discussion
Post by wofatson Feb 06, 2023 4:51pm

shorts increased

Symbol Issue Name Shares Net Change Date $GUD.TO KNIGHT THERAPEUTICS INC. 2,851,678 36,753 30 Jan 2023
274
Post by MrMugsyon Feb 04, 2023 2:16pm

Presentation says it best ...

January 2023 presentation says it best ... 1.  unique platform in high growth markets 2.  profitable business with strong revenue and adjusted EBITDA 3.  strong balance sheet 4.  ...more  
485
Discussion
Post by Chianchinon Feb 04, 2023 9:51am

Stockhouse yes you may ban me

Porky, I rest my case. Mr mugsy motives to keep posting under different aliases has nothing to do with GUD He/she/the is a paid/rewarded influencer to enhance audience participation, That is why ...more  
262
Comment by MrMugsyon Feb 03, 2023 10:19pm

RE:RE:Cheap Valuation

Hahaha - Porky and I aren't even talking about the same things. He's still sad that Meir's gone. He can't stand that GUD was built in PLB's image and there was no way to stop it ...more  
162
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities